Related Experiment Videos
Association of autoantibodies to myeloperoxidase with different forms of vasculitis
J W Tervaert1, R Goldschmeding, J D Elema
1Department of Clinical Immunology, University Hospital, Groningen, The Netherlands.
Abstract:
Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase (MPO) were found in 53 patient sera that were routinely submitted for antineutrophil cytoplasmic antibody determination. Based on clinical and histologic criteria, 15 of these 53 patients were classified as having systemic necrotizing vasculitis of the polyarteritis group, 11 patients were classified as having Wegener's granulomatosis (WG), and 14 were classified as having idiopathic crescentic glomerulonephritis. The remaining 13 patients did not fulfill the diagnostic criteria for these disorders, although most of these patients had clinical symptoms compatible with these disorders. While all patients with WG had renal involvement, only 4 of the 15 patients with systemic necrotizing vasculitis of the polyarteritis group had glomerulonephritis. The sensitivity of autoantibodies to MPO for either systemic necrotizing vasculitis of the polyarteritis group, WG, or idiopathic crescentic glomerulonephritis was further tested in all our patients with these disorders (n = 104). Twenty-seven of 104 patients had autoantibodies to MPO. Furthermore, 69 of the remaining 77 patients had autoantibodies specific for the 29-kd serine protease, which has been reported to be specifically associated with WG. Sera from 8 patients were negative for either of these antibodies (92% sensitivity of autoantibodies to MPO and/or the 29-kd serine protease). The specificity of autoantibodies to MPO for either systemic necrotizing vasculitis of the polyarteritis group, WG, or idiopathic crescentic glomerulonephritis was also tested in selected groups of patients who had closely related diseases. Two of 144 patients had autoantibodies to MPO (specificity 99%).(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Autoantibodies targeting myeloperoxidase (MPO) are significant biomarkers for diagnosing systemic necrotizing vasculitis and Wegener's granulomatosis. These MPO-specific antibodies aid in identifying patients with these autoimmune conditions.
Area of Science:
- Immunology
- Nephrology
- Rheumatology
Background:
- Antineutrophil cytoplasmic autoantibodies (ANCAs) are crucial in diagnosing vasculitis.
- Myeloperoxidase (MPO)-specific ANCAs are associated with specific forms of systemic vasculitis.
Purpose of the Study:
- To determine the diagnostic utility of MPO-specific ANCAs in patients with systemic necrotizing vasculitis, Wegener's granulomatosis (WG), and idiopathic crescentic glomerulonephritis.
- To evaluate the sensitivity and specificity of MPO-ANCAs in these patient cohorts.
Main Methods:
- Analysis of patient sera for MPO-specific ANCAs.
- Classification of patients based on clinical and histologic criteria for systemic necrotizing vasculitis, WG, and idiopathic crescentic glomerulonephritis.
- Testing MPO-ANCAs in a larger cohort (n=104) and in patients with related diseases (n=144).
Main Results:
- MPO-specific ANCAs were detected in 53 of 104 patients with systemic necrotizing vasculitis, WG, or idiopathic crescentic glomerulonephritis.
- Sensitivity for MPO-ANCAs and/or 29-kd serine protease antibodies was 92% (77/85 patients).
- Specificity of MPO-ANCAs for these conditions was high at 99% (2/144 patients in related disease groups).
Conclusions:
- MPO-specific ANCAs are sensitive and specific diagnostic markers for systemic necrotizing vasculitis, WG, and idiopathic crescentic glomerulonephritis.
- These antibodies can aid in differentiating these conditions from other autoimmune diseases.
- Further investigation into the role of MPO-ANCAs in vasculitis pathogenesis is warranted.